Illegal cosmetics on the EU market: A threat for human health?

Archives of Toxicology

Volumn 88, Issue 9, 2014, Pages 1765-1766

  Desmedt, B ^a,b   Courselle, P ^a   De Beer, J O ^a   Rogiers, V ^b   Deconinck, E ^a   De Paepe, K ^b  

^a SCIENTIFIC INSTITUTE OF PUBLIC HEALTH   (Belgium)

^b VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BLEACHING AGENT; CLOBETASOL PROPIONATE; CORTICOSTEROID; COSMETIC; DEPIGMENTING AGENT; HYDROQUINONE; ILLICIT DRUG; RETINOIC ACID;

ALLERGIC REACTION; CONSUMER; DRUG LEGISLATION; DRUG MARKETING; EUROPEAN UNION; FRANCE; GOVERNMENT REGULATION; HEALTH HAZARD; HUMAN; KIDNEY DISEASE; LETTER; LIFE THREAT; NETHERLANDS; OCHRONOSIS; PRIORITY JOURNAL; PUBLIC HEALTH; SKIN PIGMENTATION; BELGIUM; CRIME; DERMATITIS, ALLERGIC CONTACT; LEGISLATION AND JURISPRUDENCE; PACKAGING; PRODUCT SAFETY; STANDARDS; TRENDS;

BELGIUM; CONSUMER PRODUCT SAFETY; COSMETICS; CRIME; DERMATITIS, ALLERGIC CONTACT; EUROPEAN UNION; HUMANS; PRODUCT LABELING; SKIN LIGHTENING PREPARATIONS;

EID: 84906237939     PISSN: 03405761     EISSN: 14320738     Source Type: Journal    
DOI: 10.1007/s00204-014-1317-4     Document Type: Letter

References (13)

1. ANSM (2009) Agence Nationale de Sécurité du Médicament et des produits de santé. Sécurité des produits cosmétiques. http://ansm.sante.fr/Dossiers/Securite-des- produits-cosmetiques/Risques-lies-a-la-depigmentation-volontaire/(offset)/2#cos. Accessed July 2014
2. Charlín R, Barcaui CB, Kac BK, Soares DB, Rabello-Fonseca R, Azulay-Abulafia L (2008) Hydroquinone-induced exogenous ochronosis: a report of four cases and usefulness of dermoscopy. Int J Dermatol 47(1):19-23
3. Desmedt B, Rogiers V, Courselle P, De Beer J, De Paepe K, Deconinck E (2013) Development and validation of a fast chromatographic method for screening and quantification of legal and illegal skin whitening agents. J Pharm Biomed Anal 83:82-88
4. Desmedt B, Van Hoeck E, Rogiers V, Courselle P, De Beer J, De Paepe K, Deconinck E (2014) Characterization of suspected illegal skin whitening cosmetics. J Pharm Biomed Anal 90:85-91
5. EU (2009) Regulation 1223/2009, Official Journal L 342/59. http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2009:342:0059:0209: en:PDF. Accessed March 2014
6. Karamagi C, Owino E, Katabira E (2001) Hydroquinone neuropathy following use of skin bleaching creams: case report. East Afr Med J 78(4):223-224 (Pubitemid 33395025)
7. Ladizinski B, Mistry N, Kundu RV (2011) Widespread use of toxic skin lightening compounds: medical and psychosocial aspects. Dermatol Clin 29(1):111-123
8. Olumide YM, Akinkugbe AO, Altraide D, Mohammed T, Ahamefule N, Ayanlowo S, Onyekonwu C, Essen N (2008) Complications of chronic use of skin lightening cosmetics. Int J Dermatol 47(4):344-353 (Pubitemid 351486476)
9. RAPEX 2014: EU Commission Health and consumer's notification. http://ec.europa.eu/consumers/dyna/rapex/rapex-archives-en.cfm. Accessed March 2014
10. SCCNFP/0017/98 (1999) Opinion on fragrance allergy in consumers. Adopted during the plenary meeting. http://ec.europa.eu/health/ph-risk/committees/sccp/ documents/out98-en.pdf. Accessed June 2014
11. SCCS/1360/10 (2011) Opinion on Chloroacetamide, adopted during the 10th plenary meeting. http://ec.europa.eu/health/scientific-committees/consumer- safety/docs/sccs-o-053.pdf. Accessed July 2014
12. SCCS/1459/11 (2012) Opinion on fragrance allergens in cosmetic products, adopted during the 15th plenary meeting. http://ec.europa.eu/health/scientific- committees/consumer-safety/docs/sccs-o-102.pdf. Accessed July 2014
13. VWA 2009: Voedsel en waren autoriteit, Factsheet huidbleekmiddelen met hydrochinon, corticosteroïden en kwikverbindingen. https://www.vwa.nl/ txmpub/files/?p-file-id=2200594. Accessed July 2014